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egulatory proteins have been identiﬁed in embryonic
development of the endocrine pancreas. It is un-
known whether these factors can also play a role in
the formation of pancreatic endocrine cells from postnatal
nonendocrine cells. The present study demonstrates that
adult human pancreatic duct cells can be converted into
insulin-expressing cells after ectopic, adenovirus-mediated
expression of the class B basic helix-loop-helix
 
 
 
factor
neurogenin 3 (ngn3), which is a critical factor in embryo-
genesis of the mouse endocrine pancreas. Infection with
adenovirus ngn3 (Adngn3) induced gene and/or protein
 
expression of 
 
NeuroD/
 
 
 
2
 
, 
 
Pax4
 
, 
 
Nkx2.2
 
, 
 
Pax6
 
,
 
 
 
and Nkx6.1,
R
 
all known to be essential for 
 
 
 
-cell differentiation in mouse
embryos. Expression of ngn3 in adult human duct cells
induced Notch ligands Dll1 and Dll4 and neuroendocrine-
and 
 
 
 
-cell–speciﬁc markers: it increased the percentage of
synaptophysin- and insulin-positive cells 15-fold in ngn3-
 
infected versus control cells. Infection with 
 
NeuroD/
 
 
 
2
 
 (a
downstream target of ngn3) induced similar effects. These
data indicate that the Delta-Notch pathway, which controls
embryonic development of the mouse endocrine pancreas,
can also operate in adult human duct cells driving them to
a neuroendocrine phenotype with the formation of insulin-
expressing cells.
 
Introduction
 
Several studies have suggested that adult 
 
 
 
-cells might originate
from duct or duct-associated cells (Slack, 1995; Bouwens
and Pipeleers, 1998; Edlund, 1999; Bonner-Weir et al.,
2000). Evidence for this concept is largely indirect, and the
underlying mechanisms are unknown. It is also conceivable
that acinar cells can become a source of new 
 
 
 
-cells in view
of their plasticity, allowing them to transdifferentiate into
hepatocytes (Shen et al., 2000) and into duct cells (Rooman
et al., 2000). If postnatal acinar and/or duct cells could form
new 
 
 
 
-cells, they would become a particularly useful target
for therapies that aim 
 
 
 
-cell replacement in diabetic patients
(Keymeulen et al., 1998; Shapiro et al., 2000), since both
cell types are abundantly available in the pancreas of these
patients and in donor organs. To assess such potential, we
examined whether expression of key embryonic transcription
factors in adult human duct cells could induce their differ-
entiation into insulin-expressing cells.
Experiments with transgenic mice have indicated key factors
 
in the embryonic development of their endocrine pancreas.
 
Analysis of null mutants for 
 
Pdx1/Ipf1
 
, 
 
ngn3
 
, 
 
NeuroD/
 
 
 
2
 
,
 
Pax4
 
, 
 
Nkx2.2
 
, 
 
Nkx6.1
 
, or 
 
Pax6
 
 has identified a hierarchy of
transcription factors that control embryonic formation of
pancreatic islets (for review see Sander and German, 1997;
Jensen et al., 2000a; Edlund, 2001). It is unknown whether
these factors play a role in the postnatal growth of the pan-
 
creatic 
 
 
 
-cell mass and whether they can be used to induce
formation of human 
 
 
 
-cells from postnatal nonendocrine
cells. In this perspective, we examined the endocrinogenic
potential of the class B basic helix-loop-helix (bHLH)* tran-
scription factor neurogenin 3 (ngn3), which seems to function
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as a major and timely switch in the rodent embryonic pan-
creas (Gradwohl et al., 2000). When expression of ngn3 is
directed ectopically into the embryonic epithelium, pan-
creas precursor cells develop prematurely and exclusively
into glucagon-producing cells (Apelqvist et al., 1999;
Schwitzgebel et al., 2000). Similarly, ngn3 induced prema-
ture differentiation into glucagon- and somatostatin-pro-
ducing cells when introduced into early chicken endoderm
(Grapin-Botton et al., 2001). The failure to induce insulin-
producing cells might indicate that these immature cells
lack the competence to drive 
 
 
 
-cell differentiation. The dif-
ferentiating activity of ngn3 is under control of Notch sig-
naling. Indeed, null mutant mice for the Notch ligand 
 
Dll1
 
,
for an intracellular mediator of Notch signaling 
 
RBP-J
 
 
 
(Apelqvist et al., 1999), or for a downstream bHLH repres-
sor 
 
HES1 
 
(Jensen et al., 2000b), which possibly controls
 
ngn3 
 
(Tanabe and Jessell, 1996), all show premature endo-
crine differentiation. Therefore, we ectopically expressed
ngn3 in adult duct cells to assess its role as a switch activat-
ing the expression of other developmental transcription fac-
tors and Delta-Notch proteins and consequently resulting
in the appearance of endocrine differentiation markers, in
particular insulin.
 
Results
 
Absence of regulators of embryonic endocrine 
differentiation in postnatal human pancreatic duct cells
 
Adult human 
 
 
 
-cell preparations express a series of tran-
scription factors that are crucial for embryonic development
of mouse endocrine pancreas (Fig. 1 A). Transcripts en-
coding Pdx1/Ipf1, NeuroD/
 
 
 
2, Pax4, Pax6, Nkx2.2, and
Nkx6.1 were abundant in adult human islets. The expres-
sion of 
 
Pax4
 
 in human islets is at variance with its absence in
postnatal mouse islets (Smith et al., 1999) or rat-purified
 
 
 
-cells (see Fig. 4 A). A parallel analysis of adult human duct
cell transcripts shows the presence of relatively high levels
Pdx1/Ipf1 and Nkx6.1 transcripts (Fig. 1 A). Pdx1/Ipf1 is
also expressed in adult human duct cells at the protein level
(Heimberg et al., 2000), but this is not the case for Nkx6.1
(Fig. 1 B), suggesting it is subject to posttranscriptional reg-
ulation. Sections of adult human pancreas with both 
 
 
 
-cells
and duct cells clearly indicated that Nkx6.1-positive nuclei
were associated with insulin-containing cells and not with
cells that expressed the ductal cell marker CA19.9 (Bouwens
and Pipeleers, 1998) (Fig. 1 B). Ngn3 mRNA level was low
in both islets and duct cells. Compared with islet cells, the
duct cell levels of transcripts coding for Notch 1, 2, and 3 re-
ceptors were higher, those for Jagged 1 and 2 ligands were
similar, and those for Dll1 and Dll4 ligands were much
lower (see Fig. 3 C).
 
Ngn3 induces expression of regulators of embryonic 
endocrine differentiation in postnatal human 
pancreatic duct cells
 
We ectopically expressed ngn3 and its downstream target
NeuroD/
 
 
 
2 in adult human duct cells. Common transfec-
tion methods were unsuccessful, but infection with recombi-
Figure 1. Endogenous expression of 
key developmental transcription factors 
in adult human pancreatic duct cells. 
(A) RT-PCR analysis of RNA extracted 
from adult human duct cells compared 
with adult human islet cells. (B) Nkx6.1 
protein in adult human pancreas as 
determined by immunoblot of extracts 
from enriched duct or islet cells (MIN6 
were control cells), and immunostaining 
on sections of human donor pancreas. 
Bars, 10  m.
Figure 2. Specificity and efficiency of adenovirus-mediated 
transgene expression. Immunoblotted protein extracts (2  g total 
protein) (A) and immunostained monolayers (B) of noninfected and 
virally infected adult human pancreatic duct cells. Bars, 10  m. 
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nant adenoviruses (Ad) resulted in efficient expression of the
transgenes that were under control of a cytomegalovirus
(CMV) promotor (Fig. 2). Both Adngn3 and AdNeuroD/
 
 
 
2 coexpressed GFP as a reporter, and AdGFP served as
control for nonspecific viral effects. A multiplicity of infec-
tion (MOI) of 50 gave a favorable balance between infection
efficiency (30–40% GFP expression) (Fig. 2) and cell sur-
vival (
 
 
 
85% living cells).
1 d after ngn3 infection, 
 
Pax4
 
 gene expression was acti-
vated (Fig. 3 A) together with 
 
Dll1
 
 and 
 
Dll4
 
, the latter two
to similar levels as in control islet preparations (Fig. 3 C).
2 d later, 
 
NeuroD/
 
 
 
2
 
 was induced, followed by 
 
Nkx2.2
 
 and
 
Pax6
 
 (Fig. 3 A). The Pdx1/Ipf1 gene remained silent or con-
stant in, respectively, monolayer or suspension cultures of
Adngn3-infected duct cells (unpublished data). These effects
were confirmed by in situ hybridization and immunocy-
tochemistry. 10 d after infection, many cells expressed either
Nkx2.2 or ngn3 (Fig. 3 B, f, arrowheads) but rarely both.
However, some Nkx2.2-expressing cells still contained GFP
(Fig. 3 B, f, arrow). There was no significant increase in the
level of Nkx6.1-encoding mRNA, but the protein appeared
abundant (Fig. 3 B, j). Nuclear protein extracts from
Adngn3-infected duct cells showed gel retardation of E box-
1 and E box-3 sequences from the 
 
NeuroD/
 
 
 
2
 
 promotor
(unpublished data). Compared with ngn3, NeuroD/
 
 
 
2-in-
duced changes in gene expression were similar but appeared
with a several days delay (unpublished data). The same re-
combinant Ad constructs were used to infect the clonal neu-
roendocrine cell line PC12 and the unrelated HeLa cell line.
In PC12 cells, which endogenously express NeuroD/
 
 
 
2 and
Nkx2.2, both ngn3 and NeuroD/
 
 
 
2 induced 
 
Pax4
 
 but not
 
Nkx6.1
 
 (Fig. 4 A). In HeLa cells, none of these endocrino-
genic transcription factors were induced after infection with
Adngn3 or AdNeuroD/
 
 
 
2.
Figure 3. Effect of adenovirus-mediated 
ectopic expression of ngn3 or NeuroD/ 2 
on key transcription factors and signal 
transduction proteins in adult human 
duct cells. (A) RT-PCR analysis of 
RNA encoding key developmental 
transcription factors from control and 
virus-infected duct cells and islets. 
Adngn3-expressed mouse ngn3 and 
AdNeuroD/ 2-expressed rat NeuroD/ 2. 
(B) Analysis of the effects of ngn3 (b, d, f, 
h, j, and l) compared with AdGFP-infected 
control cells (a, c, e, g, i, and k) at the 
cellular level by in situ hybridization of 
NeuroD/ 2 (a and b) and Pax4 (c and d) 
mRNA and immunofluorescence for 
Nkx2.2 (e–h), ngn3 (e and f), Nkx6.1 
(i and j) and Pax6 (k and l). Sections 
for immunocytochemistry underwent 
short (1 h) fixation to preserve GFP 
fluorescence. Arrowheads in panel f point 
to cells expressing either Nkx2.2 or 
ngn3 (intense red, respectively, green 
nuclear staining), and arrow points to a 
cell expressing Nkx2.2 and still containing 
GFP (weak green fluorescence in 
cytoplasm combined with weak red 
staining in the nucleus) without high 
level expression of ngn3. Panels g and h 
represent a combination of phase–contrast 
and fluorescence microscopy (Nkx2.2 
immunostaining), emphasizing the 
massive effect of ngn3. Bars, 10  m. 
(C) RT-PCR analysis of RNA encoding 
Notch, Jagged, and Delta isoforms from 
control and virus-infected duct cells and 
human islets. 
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Ngn3 induces expression of neuroendocrine markers, 
in particular insulin, in postnatal human pancreatic 
duct cells
 
Control duct cell preparations were negative by RT-PCR
analysis for the endocrine cell markers synaptophysin, chro-
mogranin A, and prohormone convertases (PC1/3 and
PC2), and for the islet cell markers insulin, somatostatin,
glucagon, glucose transporter type II, and glucokinase.
Transcripts encoding these proteins were clearly present in
the human islet cell fraction (Fig. 5 A; not depicted). 10 d
after infection with Adngn3 or AdNeuroD/
 
 
 
2, duct cell
preparations exhibited a strong activation of synaptophysin,
chromogranin A, and PC1/3 gene expression, and a weaker
increase for the glucokinase and insulin genes (Fig. 5 A). No
signals were detected for Glut2, somatostatin, or glucagon
transcripts. These effects of ectopic ngn3 expression were
also reflected at the protein level (Fig. 5 B). The fraction of
cells that were immunopositive for insulin and synapto-
physin increased from 1% in control preparations to, respec-
tively, 13 and 22% 10 d after Adngn3 infection. The per-
centage of glucagon- or somatostatin-positive cells remained
under 2% (unpublished data). However, although ectopic
ngn3 did not affect the number of glucagon-containing
cells, it increased the percentage of somatostatin-positive
cells 3.5-fold (0.2 
 
 
 
 0.1% versus 0.7 
 
 
 
 0.1%, P 
 
 
 
 0.05;
 
n 
 
  
 
4). A similar effect was observed after infection with Ad-
NeuroD/
 
 
 
2. Interestingly, most cells that expressed these
endocrine markers were negative for ngn3 (Fig. 5 B, b, c,
and g, arrowheads point to single positive cells). At this time
point, the percentage of ngn3-positive cells was markedly
lower than at day 3. Furthermore, the rare ngn3-positive
cells that coexpressed endocrine markers exhibited a much
lower ngn3 fluorescence intensity than those that did not
(Fig. 5 B, b and g, arrows).
10 d after Adngn3 infection, many but not all synapto-
physin-positive cells expressed chromogranin A (Fig. 5 B, k
and l). More than 90% of the synaptophysin-expressing cells
were still positive for the duct cell marker cytokeratin
(CK)19 (Fig. 5 B, i); however, this was the case for only part
of the insulin- or somatostatin-positive cells (Fig. 5 B, h and
j; not depicted). Electronmicrographs confirmed the pres-
ence of a large percentage of ngn3-infected cells with secre-
tory granules (Table I) that were, however, smaller than the
characteristic large granules of fully differentiated endocrine
islet cells (Fig. 5 C).
Ectopic ngn3 or NeuroD/
 
 
 
2 expression in postnatal hu-
man pancreatic duct cells resulted in a threefold increase in
the insulin content and insulin release of the preparations
(Table II). In view of the 10-fold increase in the percentage
of insulin-positive cells, these data suggest that the newly
formed insulin-positive cells have a low insulin content.
In PC12 cells, ngn3 and NeuroD/
 
 
 
2 induced insulin ex-
pression, both at the transcript and protein level (Fig. 4) but
failed to induce glucokinase, Glut2, somatostatin or glucagon.
No ngn3-induced gene expression was seen in HeLa cells.
Figure 4. Effect of adenovirus-mediated expression of ngn3 or 
NeuroD/ 2 in the neuroendocrine cell line PC12. (A) RT-PCR 
analysis of RNA encoding Pax4 and insulin from control and virus-
infected PC12 cells and purified rat  -cells. (B) Immunostaining of 
insulin in PC12 cells that were infected at low MOI with Adngn3. 
Arrow points to insulin-positive PC12 cell that still contains lots of 
active GFP; arrowheads point to PC12 cells that express insulin but 
contain no active GFP or ngn3 anymore. Bars, 10  m.
 
Table I. 
 
Effect of ngn3 or NeuroD/
 
 
 
2 on the fraction of granulated 
and synaptophysin- or insulin-positive cells
Granulation
 
 
 
n
 
 
 
 
 
 3
Synaptophysin
 
 
 
n
 
 
 
 
 
 3
Insulin
 
 
 
n
 
 
 
 
 
 3
 
%% %
 
AdGFP
 
  
 
2
 
 
 
 2
 
 
 
 2
Adngn3 10 
 
 
 
 2
 
a
 
22   4
a 13   3
a
AdNeuroD/ 28     4
a 10   1
a 8   2
a
Granulation was analyzed by EM and synaptophysin and insulin positivity
by immunostaining. Results are the average   standard error of the mean
of n independent duct cell preparations infected with AdGFP, Adngn3, or
AdNeuroD/ 2 expressed as a percentage of total cells.
aP   0.05 versus AdGFP-infected duct cells as determined by the paired
Student’s t test.
Table II. Effect of ngn3 or NeuroD/ 2 on the relative 
concentration of insulin in duct cells and duct cell
culture medium
Insulin content
n   4
Insulin release
n   3
AdGFP 100 100
Adngn3 250   60
a 340   20
a
AdNeuroD/ 2 310   50
a 330   20
a
Insulin release was measured as the amount of insulin that accumulated in
the medium during 48 h. Results are the average   standard error of the
mean of n independent duct cell preparations infected with AdGFP,
Adngn3, or AdNeuroD/ 2 expressed as percentage of AdGFP-infected
control cells.
aP   0.05 versus AdGFP-infected duct cells as determined by the paired
Student’s t test. Neuroendocrine transdifferentiation by ngn3 | Heremans et al. 307
Discussion
The present study demonstrates that adenovirus-mediated
delivery of ngn3, a key transcription factor for the genera-
tion of endocrine islet cells in mouse embryos, shifts adult
human pancreatic duct cells into a neuroendocrine pheno-
type with expression of insulin in a significant fraction of
transdifferentiated cells. It is unlikely that this effect requires
the participation of Pdx1/Ipf1. This transcription factor is
expressed in adult human pancreatic duct cell suspensions,
be it at lower abundance and with a different phosphory-
lation status and DNA-binding activity compared with
mature human islet cells (Heimberg et al., 2000); however,
the ngn3-induced (neuro)endocrine differentiation was also
achieved in duct cell monolayers, which are negative for
Pdx1/Ipf1 (unpublished data). Of the known developmental
transcription factors that operate downstream of Pdx1/Ipf1
to specifically control embryonic pancreas formation, ngn3
comes first in sequence. Ngn3 is a major regulator of lateral
inhibition that controls endocrinogenesis in the embryonic
mouse pancreas (Apelqvist et al., 1999). It has been pro-
posed as a marker for pancreatic islet progenitor cells during
embryogenesis and in adult mice (Jensen et al., 2000a; Gu et
al., 2002). The amplified signal for ngn3 transcript in duct
cells was similar to islets and suggests very low but specific
expression in this cell fraction. Adenovirus-mediated overex-
pression of ngn3 in adult human pancreatic duct cells was
found to activate expression of neuroendocrine differentia-
tion markers and of  -cell–specific genes Pax4 and insulin.
Despite their independence of Pdx1/Ipf1, the requirement
for ngn3 and the induction of Pax4 and somatostatin expres-
sion suggest that the ngn3-transdifferentiated (neuro)endo-
crine cells resemble cells of the second rather than the first
wave of pancreatic endocrinogenesis. The described effects
are cell type restricted, since they were reproduced in the
PC12 neuroendocrine cell line but not in HeLa cells.
It is unknown presently whether this forced transdifferen-
tiation is restricted to a subpopulation of duct cells. A major
proportion of ngn3-infected cells expressed the (neuro)en-
Figure 5. Effect of adenovirus-mediated 
ectopic expression of ngn3 or NeuroD/ 2 
on markers of the differentiated 
endocrine phenotype in adult human 
duct cells. (A) RT-PCR analysis of RNA 
encoding endocrine marker proteins in 
adult human duct cells and islet cells. 
(B) Immunostaining of control (AdGFP-) 
(a and f, inset) and Adngn3- (b and j) 
infected duct cells. Nuclei stained blue 
by DAPI (a, b, d, g, h, and j). All 
immunoreactions were labeled with a 
fluorescent secondary antibody except 
for panel f which was immunochemically 
stained (ABC peroxidase). Panel j 
represents a double labeling for CgA 
(FITC) and Syn (Cy3). Panels c and e 
represent a combination of phase–
contrast and fluorescence microscopy. 
Noninfected and control-infected duct 
cells contained a low number of 
endocrine cells ( 1% insulin positivity 
and  2% synaptophysin positivity). 
Endocrine marker proteins were 
chromogranin A (CgA), synaptophysin 
(Syn), prohormone convertase 1/3 (PC1/3), 
and insulin (Ins); duct cell marker was 
CK19. Noninfected and GFP control-
infected duct cells contained none of the 
endocrine proteins under study as 
determined by costaining for the duct 
cell markers CK19 or CA19.9. Bars, 10 
 m. Sections for immunocytochemistry 
underwent overnight fixation which 
abolished GFP fluorescence. Arrowheads, 
single positive cells on panels b and c 
(either ngn3 or CgA), g (insulin), and j 
(Syn); arrows, cells coexpressing CgA 
and ngn3 (b), insulin and ngn3 (g), or 
CgA and Syn (j). (C) Electron micrograph 
of control (a) and transdifferentiating (b) 
adult human pancreatic duct cells 10 d 
postinfection with AdGFP (a) or Adngn3 
(b). Adngn3-infected cells display 180-nm 
secretory granules with a homogenous, 
electron dense matrix. Bars, 1  m.308 The Journal of Cell Biology | Volume 159, Number 2, 2002
docrine markers, but only a fraction was insulin posi-
tive. The sequential activation of a comprehensive set of
(neuro)endocrine-specific genes rather than the existence of
(sub)populations of cells expressing only few individual
markers is characteristic for the induction of a coordinated
differentiation program. Based on its rapid nature and inde-
pendence of cell proliferation (unpublished data), this pro-
cess likely represents immediate transdifferentiation of the
duct cells without the need for an intermediate cellular state
(Shen et al., 2000; Slack and Tosh, 2001). Transdifferenti-
ated cells are characterized by coexpression of the duct cell
marker CK19 and the neuroendocrine marker synapto-
physin. Such double positive cells are virtually absent in
noninfected duct cell preparations. The expression levels of
both markers changed gradually and reciprocally with time
after infection. Only little cytokeratin positivity was left in
the cells that finally expressed insulin. A combination of the
transient nature of the adenoviral expression system and the
elimination of fluorescence by GFP after extended fixation
allowed simple tracing of cell fate. A direct relation between
the ngn3-infected duct cells and the cells that became posi-
tive for endocrine markers was observed. Rare cells coex-
pressed endocrine marker proteins and traces of ngn3, sug-
gesting a causal relationship between expression of ngn3 and
the endocrine protein. Furthermore, several endocrine cells
still contained the stable green fluorescent protein that re-
mains present for days after its transcript, and consequently
the mRNA encoding the less stable ngn3 protein, have dis-
appeared (Corish and Tyler-Smith, 1999).
The mechanism whereby ngn3 induces duct cell differen-
tiation into endocrine  -cells seems to involve activation of
the Pax4 and the NeuroD/ 2 promotor. Ngn3 is known to
activate NeuroD/ 2 expression in chicken embryos (Grapin-
Botton et al., 2001), Xenopus embryos, and (neuro)endo-
crine cell lines (Huang et al., 2000). This is also the case in
HeLa cells that had been transfected with E47, a class A
bHLH heterodimerization partner of ngn3 (Huang et al.,
2000). Adult human duct cells contain high endogenous
levels of E47 (unpublished data), allowing E-box binding of
the ectopically expressed ngn3 and activation of the NeuroD/
 2 promotor. The delayed induction of NeuroD/ 2 by ngn3
suggests the existence of intermediate transcription factors.
Moreover, the delay in NeuroD/ 2-induced Pax4 activation
compared with ngn3 uncovers that both Pax4 and NeuroD/
 2 are ngn3 targets, instead of Pax4 being downstream of
NeuroD/ 2. The present study thus supplements the hierar-
chy model of transcription factors involved in the formation
of embryonic  -cells (Schwitzgebel et al., 2000). It also
demonstrates that the embryological program in mice can
be recapitulated in postnatal human duct cells, leading to
formation of insulin, and to a minor extent somatostatin-
expressing cells. In experimental terms, adult duct cells in-
fected with adenoviruses expressing recombinant tran-
scription factors are a simple in vitro model for studying the
molecular biology of endocrine transdifferentiation.
Ectopic expression of ngn3 or NeuroD/ 2 in isolated
adult duct cells activates several (neuro)endocrine-specific
genes, such as insulin and somatostatin, but not glucagon.
In mouse or chicken embryonic endoderm cells in vivo, ec-
topic ngn3 induces glucagon but not insulin (Grapin-Bot-
ton et al., 2001). Activation of  -cell–specific Pax4 in duct
cells might be responsible for the absence of glucagon ex-
pression (Smith et al., 1999; Petersen et al., 2000). The role
of Nkx2.2 and Nkx6.1 in this transdifferentiation process is
unclear: Nkx2.2 was stimulated by ngn3 at the transcrip-
tional level, and Nkx6.1 was stimulated at the posttranscrip-
tional level. Both transcription factors appear essential dur-
ing embryonic development of  -cells, with Nkx2.2 acting
upstream of Nkx6.1 (Sander et al., 2000). Adngn3-infected
duct cells failed to generate glucose-induced insulin release
within the limits of the present study, i.e., 10 d after infec-
tion (unpublished data). Our study can thus not be taken as
evidence for the ability to produce functionally mature
 -cells from pancreatic duct cells. Nevertheless, the data are
indicative for a selective ability of adult duct cells to differenti-
ate toward (neuro)endocrine and islet cells. Ngn3 induced
moderate to high expression of synaptophysin, chromogra-
nin A, PC1/3, and glucokinase, but the degree of insulin
gene activation is low and so is the cellular insulin content.
Transdifferentiated pancreatic duct cells exhibit the ultra-
structural characteristics of immature endocrine cells, which
is consistent with the absence of a glucose-regulated secre-
tory activity. The absence of Glut2 induction is compatible
with the earlier report that Glut2 is poorly expressed in hu-
man  -cells compared with human liver cells or rodent
 -cells (De Vos et al., 1995).
The incomplete differentiation of this particular pheno-
type might be caused by, or related to, a variety of factors. (a)
Although Pax4 is subject to autoregulation in mouse islet cell
lines (Smith et al., 2000), ngn3-induced activation of Pax4
in human duct cells was not. This allows the relatively high
levels of Pax4 to exert their inhibitory action on insulin gene
expression (Qiu et al., 1998; Smith et al., 1999). Low levels
of Pax4 also occurred in normal adult human islet cells in
contrast to its restriction to the embryonic mice pancreas
(Sosa-Pineda et al., 1997; Smith et al., 1999, 2000). It is
likely that in mature islet  -cells a yet unknown factor over-
rules the Pax4 repressor activity. Given the transient pres-
ence of ngn3 and Pax4 in the embryonic mouse pancreas, it
needs to be investigated whether a closer simulation of the
embryonic situation by conditional expression of ngn3 in
adult human duct cells would augment the insulin levels. (b)
The state of the Delta-Notch pathway probably also has its
influence on the degree of (neuro)endocrinogenesis. In unin-
fected duct cells, high levels of Notch1, 2, and 3 but not of
Dll1, 3, and 4 were found. Ngn3 infection activated tran-
scription of Dll1 and Dll4 and thus increased Notch signal-
ing in neighboring pairs, which is expected to limit overall
endocrine differentiation. It may thus be useful to add anti-
morphic forms of Delta that antagonize Notch signaling (Jen
et al., 1997) or to introduce ngn3 targets that bypass stimu-
lation of Delta genes in order to specifically drive the forma-
tion of endocrine cells. (c) The transdifferentiated cells likely
are dependent on extracellular factors to promote their mat-
uration. (d) Finally, repression of specific proneural regula-
tors induced by ngn3 may be necessary to allow full endo-
crine differentiation. Although the transdifferentiated duct
cells did not express genes that label differentiated neuronal
cells (N-Cam, neurofilament, peripherin, and class III  -tubu-
lin [unpublished data]), major overlaps exist between the Neuroendocrine transdifferentiation by ngn3 | Heremans et al. 309
expression profile of endocrine pancreas and neurons (Atouf
et al., 1997; unpublished data). These similarities were key
to design conditions that drive embryonic stem cells to insu-
lin production (Lumelsky et al., 2001). Moreover, insulin-
producing cells are present in primary cell cultures from
mammalian fetal brain (Clarke et al., 1986), and insulin-
producing neurons in Drosophila brain show remarkable
similarities with  -cells in mammalian islets of Langerhans
(Rulifson et al., 2002). All these data are highly suggestive
for a common ancestral insulin-producing cell of neural ori-
gin, which complicates the identification of specific proneu-
ral factors that are nonessential for islet cell differentiation.
In more general terms, the present findings extend the
role of lateral inhibition in cell differentiation from embry-
onic, poorly differentiated tissues (Artavanis-Tsakonas et al.,
1999) to postnatal differentiated cell populations. Adult hu-
man duct cells were shown to transdifferentiate into neu-
roendocrine and into insulin-producing cells after ectopic
expression of ngn3. Pancreatic duct and islet cells have a
common embryonic progenitor, but according to a recent
lineage tracing study ngn3 is never expressed in duct cells or
their progenitors (Gu et al., 2002). However, our current
study shows that ngn3 might serve as a master switch that
drives transdifferentiation to a (neuro)endocrine phenotype
when misexpressed in adult duct cells. It is still unknown
whether ngn3 can be activated by environmental factors in
normal duct cells of regenerating postnatal pancreas and
thus result in the formation of new  -cells. Current efforts
focus on finding ways to differentiate embryonic stem cells
into insulin-producing cells with the purpose of producing
sufficient cells for transplantation in diabetes (Assady et al.,
2001; Lumelsky et al., 2001). Our observations have indi-
cated mechanisms through which adult duct cells could be
forced to differentiate into insulin-producing cells. The
abundance of duct cells and the ease of their in vitro manip-
ulation support further attempts to explore their potential as
a source for new  -cells.
Materials and methods
Production of recombinant adenoviruses
Adenoviral plasmid pAdEasy-1 and shuttle vector pAdTrack-CMV were
made available by T.-C. He and B. Vogelstein (Johns Hopkins Oncology
Center, Baltimore, MD). Coding sequences of hemagglutinin-tagged
mouse ngn3 or rat NeuroD/ 2 were subcloned in the shuttle vector and
constitutively expressed under control of the CMV promotor. pAdTrack-
CMV contained the eGFP cDNA downstream of a separate CMV pro-
motor. Recombinant, replication-deficient adenoviruses expressing GFP
(AdGFP), ngn3 in combination with GFP (Adngn3), or NeuroD/ 2 in com-
bination with GFP (AdNeuroD/ 2) were generated following the standard
protocol as described by He et al. (1998).
Cell isolation and cell culture
The duct cells in this study were obtained from heart-beating cadaveric
nondiabetic donors as the discarded fraction of an islet cell isolation to
prepare grafts for transplantation in type I diabetes patients. Human donor
pancreases were procured at European hospitals and made available to the
 -Cell Bank in Brussels through the intermediate of Eurotransplant Founda-
tion (Leiden, The Netherlands). The endocrine preparations contained
 60% hormone-positive cells (Keymeulen et al., 1998). In the nonendo-
crine fraction,  2% expressed islet cell markers and  90% expressed the
duct cell–specific phenotypic markers cytokeratin 19 and carbohydrate
antigen 19.9 when cultured for at least 4 d (Bouwens et al., 1994). The
nonendocrine cell preparation was cultured in suspension in Ham’s F10
(Bio-Whittaker), 0.5% BSA (Boehringer Mannheim), 7.5 mM glucose, 100
U/ml penicillin, 100  g/ml streptomycin, and 1 mM L-glutamine at 37 C in
a humidified atmosphere of 5% CO2. 24 h after isolation, the cells were
washed, and the medium was renewed. On day 4 of culture, cells were
counted and were infected and further cultured in suspension. Alterna-
tively, day 4 cells were plated to form monolayers in the presence of 5%
FBS (Life Technologies) and infected 6 d later. Under all conditions, cell
culture medium was renewed every other day.
PC12 cells were cultured in suspension in RPMI 1640 with Glutamax
(Life Technologies), 10% FBS, 100 U/ml penicillin, and 100  g/ml strepto-
mycin at 37 C in a humidified atmosphere of 5% CO2. Rat  -cells were
prepared as described before (Heimberg et al., 1996).
Viral infection of isolated exocrine cells and PC12 cells
Cells were either infected with control virus (AdGFP) or with Adngn3 or
AdNeuroD/ 2 as described previously (Heimberg et al., 2001). Adult hu-
man duct cells were infected at an MOI of 50 for 4 h at 37 C. PC12 cells
were infected at an MOI 20 for 4 h at 37 C.
Protein analysis
Immunohistochemical analysis was performed on 4- m-thick paraffin sec-
tions by indirect immunofluorescence as described (Heimberg et al.,
2000). Similar methods were applied to cells from suspension cultures af-
ter fixation for 1 h in 4% paraformaldehyde and pelleting in 2% agarose
before paraffin embedding. Before incubation with the first antibody, sec-
tions for CK19 staining were trypsin treated. Rabbit polyclonal PC1/3 anti-
serum was from I. Lindberg (Louisiana State University Health Sciences
Center, New Orleans, LA) (Vindrola and Lindberg, 1992), rabbit poly-
clonal anti-ngn3 was from M. German (University of California San Fran-
cisco, San Francisco, CA), rabbit polyclonal Pax6 was from S. Saule (Insti-
tut Curie, Paris, France), and guinea pig polyclonal insulin was from C.
Van Schravendijck (Brussels Free University). The mouse monoclonal anti-
Nkx2.2 was developed by T. Jessell (Columbia University, New York, NY)
and obtained from the Developmental Studies Hybridoma Bank (Univer-
sity of Iowa, Iowa City, IA). Rabbit polyclonal anti-Nkx6.1 has been de-
scribed before (Oster et al., 1998). Rabbit polyclonal antisomatostatin was
from J. DeMey (Brussels Free University), mouse monoclonal anti–chro-
mogranin A was from Biogenex, rabbit polyclonal antisynaptophysin was
from Novocastra, mouse monoclonal anti–cytokeratin 19 was from Dako,
mouse monoclonal anti–CA19–9 from Biomed, and mouse monoclonal
anti-HA was from Boehringer. Secondary antibodies were Cy3- or FITC-
labeled anti–rabbit, anti–mouse, and anti–guinea pig (Jackson ImmunoRe-
search Laboratories). Immunoblot analysis was done as described before
(Heimberg et al., 2000).
mRNA analysis
Total RNA was isolated using RNEasy columns (QIAGEN) and reverse tran-
scription followed by PCR were performed and analyzed as described (Heim-
berg et al., 1996). Primers specifically amplified human Pdx1/Ipf1 (277 bp),
5 -CTGCCTTTCCCATGGATGAA-3  (forward) and 5 -CGCTTCTTGTC-
CTCCTCCTTT-3  (reverse), human ngn3 (286 bp), 5 -AGACGACGC-
GAAGCTCACC-3  (forward) and 5 -AAGCCAGACTGCCTGGGCT-3  (re-
verse), human NeuroD/ 2 (439 bp), 5 -ATCCCAACCCACCACCAACC-3 
(forward) and 5 -CAGCGGTGCCTGAGAAGATT-3  (reverse), human Pax4
(496 bp), 5 -AGGAGGACCAGGGACTACCGT-3  (forward) and 5 -TTT-
AGGTGGGGTGTCACTCAG-3  (reverse), human Pax6 (301 bp), 5 -
CAAAAGTCCAAGTGCTGGACAA-3  (forward) and 5 -CCCATCTGT-
TGCTTTTCGCT-3  (reverse), human Nkx2.2 (329 bp), 5 -TGCAGCACAT-
GCAGTACAACG-3  (forward) and 5 -TCCCAAGGTTCAGAAGGAGAGG-
3  (reverse), human Nkx6.1 (284 bp), 5 -TCTTCTGGCCCGGGGTGATG-
3  (forward) and 5 -AGCCGCGTGCTTCTTCCTCC-3  (reverse), human
Notch1 (160 bp), 5 -GAATCCAACCCTTGTGTCAAC-3  (forward) and 5 -
GCAACGTCGTCAATACACGTG-3  (reverse), human Notch2 (231 bp), 5 -
CGCTGCATTGACCTGGTCAAT-3  (forward) and 5 -TACATGTTGCAC-
CCTTGCGA-3  (reverse), mouse Notch3 (240 bp), 5 -GGCATTGCTAGCT-
TCTCGTGT-3  (forward) and 5 -CATAACGGTTGATGCCATCAC-3  (re-
verse), human Jagged1 (417 bp), 5 -ATCTGTCCACCTGGCTATGCAG-3 
(forward) and 5 -ATTTGCCTCCCGACTGACTCTT-3  (reverse), human
Jagged2 (338 bp), 5 -GGAAGCCATGCCTTAACGCTT-3  (forward) and 5 -
GCTCACAAAGGTCGACATCCA-3  (reverse), human Delta1 (309 bp), 5 -
CCTGATGACCTCGCAACAGAA-3  (forward) and 5 -CATGCTGCTCAT-
CACATCCAG-3  (reverse), human Delta4 (273 bp), 5 -ACCACTTCGGC-
CACTATGTGT-3  (forward) and 5 -TCTTGGTCACAAAACAGGCCT-3  (re-
verse), human synaptophysin (214 bp), 5 -GCCACATGCGGCAGCTA-
CAG-3  (forward) and 5 -ACACGGCCACGGTGACAAAG-3  (reverse), hu-
man chromogranin A (286 bp), 5 -CCGCTGTCCTGGCTCTTCT-3  (for-
ward) and 5 -CCGCTGTGTTTCTTCTGCTG-3  (reverse), human/rat insulin310 The Journal of Cell Biology | Volume 159, Number 2, 2002
(438 bp), 5 -GCAGCCTTTGTGAACCAACA-3  (forward) and 5 -TCTGCG-
GTCATCAAATGAGG-3  (reverse), human glucagon (221 bp), 5 -CCCAA-
GATTTTGTGCAGTGGTT-3  (forward) and 5 -GCGGCCAAGTTCTTCAA-
CAAT-3  (reverse), human glucokinase (607 bp), 5 -CTGGACGACA-
GAGCCAGGAT-3  (forward) and 5 -TCACCATTGCCACCACATCCAT-3 
(reverse), human PC1/3 (355 bp), 5 -CAAGATACCAGGATGACGGCA-3 
(forward) and 5 -GCCTCAATAGCATCCGTCACA-3  (reverse), mouse ngn3
(288 bp), 5 -CCGGATGACGCCAAACTTACA-3  (forward) and 5 -ACAC-
CAGTGCTCCCGGGAG-3  (reverse), rat NeuroD/Beta2 (300 bp), 5 -
GGACTTTCTTGCCTGAGCAGA-3  (forward) and 5 -AACTCGGTGGATG-
GTTCGTGT-3  (reverse), rat Pax4 (224 bp), 5 -ATGCGACCCTGTGA-
CATCTCA-3  (forward) and 5 -AAGCCCTTCAGCACAAAGCTG-3  (re-
verse), rat Nkx2.2 (209 bp), 5 -CATGTCGCTGACCAACACAAAG-3  (for-
ward) and 5 -TCGCTGCTGTCGTAGAAAGGA-3  (reverse), and rat/human
 -actin (361 bp), 5 -AGAGCTATGAGCTGCCTGAC-3  (forward) and 5 -
CTGATCCACATCTGCTGGAA-3  (reverse). For in situ hybridization, hu-
man-specific NeuroD/ 2, Pax4, and ngn3 PCR products were subcloned
into the pGEM-T Easy vector (Promega) and SalI linearized (Life Technolo-
gies). Digoxigenin-labeled transcripts were produced according to manu-
facturer’s instructions (MAXI Script; Ambion). RNA in situ hybridization
was performed as described (Gradwohl et al., 2000; Petersen et al., 2000).
Detection of hybridized probes made use of an alkaline phosphatase-
labeled antidigoxigenin antibody (Boehringer) and the substrate BM-Purple
(Boehringer).
Electron microscopy
Cell preparations were fixed in 2.5% glutaraldehyde in 0.1 M sodium ca-
codylate buffer (pH 7.4), postfixed in 1% osmium tetroxide, stained with
2% uranyl acetate, embedded in Spurr’s resin, and ultra thin plastic sec-
tions were examined with a ZEISS EM 9S2 electron microscope.
Data analysis
Results obtained from infected cells were compared with uninfected and/
or control virus-infected cells and statistically analyzed using the paired
Student’s t test.
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